MLEC
Price
$0.57
Change
+$0.01 (+1.79%)
Updated
Nov 19, 01:28 PM (EDT)
Capitalization
6.07M
22 days until earnings call
Intraday BUY SELL Signals
NAGE
Price
$6.94
Change
+$0.08 (+1.17%)
Updated
Nov 19, 01:52 PM (EDT)
Capitalization
547.47M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLEC vs NAGE

Header iconMLEC vs NAGE Comparison
Open Charts MLEC vs NAGEBanner chart's image
Moolec Science SA
Price$0.57
Change+$0.01 (+1.79%)
Volume$100
Capitalization6.07M
Niagen Bioscience
Price$6.94
Change+$0.08 (+1.17%)
Volume$200
Capitalization547.47M
MLEC vs NAGE Comparison Chart in %
MLEC
Daily Signal:
Gain/Loss:
NAGE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MLEC vs. NAGE commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLEC is a Hold and NAGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (MLEC: $0.56 vs. NAGE: $6.86)
Brand notoriety: MLEC and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLEC: 21% vs. NAGE: 70%
Market capitalization -- MLEC: $6.07M vs. NAGE: $547.47M
MLEC [@Biotechnology] is valued at $6.07M. NAGE’s [@Biotechnology] market capitalization is $547.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLEC’s FA Score shows that 1 FA rating(s) are green whileNAGE’s FA Score has 1 green FA rating(s).

  • MLEC’s FA Score: 1 green, 4 red.
  • NAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, NAGE is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLEC’s TA Score shows that 4 TA indicator(s) are bullish while NAGE’s TA Score has 5 bullish TA indicator(s).

  • MLEC’s TA Score: 4 bullish, 2 bearish.
  • NAGE’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, NAGE is a better buy in the short-term than MLEC.

Price Growth

MLEC (@Biotechnology) experienced а -10.21% price change this week, while NAGE (@Biotechnology) price change was -4.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

MLEC is expected to report earnings on Dec 11, 2025.

NAGE is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($547M) has a higher market cap than MLEC($6.07M). NAGE YTD gains are higher at: 29.312 vs. MLEC (-93.036). NAGE has higher annual earnings (EBITDA): 18.1M vs. MLEC (-5.24M). NAGE has more cash in the bank: 60.3M vs. MLEC (926K). NAGE has less debt than MLEC: NAGE (3.29M) vs MLEC (22.1M). NAGE has higher revenues than MLEC: NAGE (116M) vs MLEC (7.83M).
MLECNAGEMLEC / NAGE
Capitalization6.07M547M1%
EBITDA-5.24M18.1M-29%
Gain YTD-93.03629.312-317%
P/E RatioN/A28.58-
Revenue7.83M116M7%
Total Cash926K60.3M2%
Total Debt22.1M3.29M671%
FUNDAMENTALS RATINGS
NAGE: Fundamental Ratings
NAGE
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
24
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLECNAGE
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
60%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MLEC
Daily Signal:
Gain/Loss:
NAGE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POSAX8.94N/A
N/A
Principal Global Real Estate Sec A
MSDOX15.72N/A
N/A
Morgan Stanley Emerging Mkt ex China C
TVSVX19.98N/A
N/A
Third Avenue Small Cap Value Investor
CSXRX56.87-0.43
-0.75%
Calvert US Large Cap Core Rspnb Idx R6
RCMPX17.42-0.19
-1.08%
Lazard International Quality Gr R6

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with SPRB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
+0.30%
SPRB - MLEC
51%
Loosely correlated
+6.08%
CTMX - MLEC
42%
Loosely correlated
+3.38%
AAVXF - MLEC
38%
Loosely correlated
+3.14%
ABEO - MLEC
36%
Loosely correlated
-0.67%
NAGE - MLEC
33%
Poorly correlated
-1.01%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-1.01%
AXON - NAGE
43%
Loosely correlated
-1.74%
IRON - NAGE
41%
Loosely correlated
+0.10%
AMRN - NAGE
35%
Loosely correlated
+4.33%
CYTK - NAGE
35%
Loosely correlated
-1.19%
ARRY - NAGE
34%
Loosely correlated
-3.82%
More